Drugs / docetaxol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01963702 | Aug 2012 → Dec 2013 | gastric cancer | Fudan University | Unknown | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT04165993 Background | Dec 2019 → May 2021 | breast cancer | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Unknown | No outcome recorded |
| Phase 2 | NCT00717951 Background | May 2008 → Dec 2009 | breast cancer | Academy Military Medical Science, China | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Docetaxol | “30 mg/kg Q3W KN026 75 mg/m2 docetaxol” NCT04165993 ↗ |